Alternate Donor Study of Pre-Emptive Cellular Therapy

NCT01220895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Infection

Interventions

BIOLOGICAL: CMV-specific T-cells, single infusion following single positive CMV PCR result

Sponsor

Cell Medica Ltd

Collaborators

[object Object]
[object Object]
[object Object]